Milk Thistle Extract.

Silybin is poorly water soluble and poorly absorbed on its own, and complexing it with phosphatidylcholine raises systemic exposure by several fold. The phospholipid complex is the long-standing delivery form for silymarin flavonolignans.

Lecithin supplies the same phosphatidylcholine-rich phospholipid matrix used to disperse silymarin in oil and mixed micelles. It improves dissolution of a flavonolignan that otherwise passes largely unabsorbed.

NAC supplies cysteine, the rate-limiting substrate for glutathione synthesis in liver cells. Silymarin acts on the same glutathione economy from the sparing side, so the two cover substrate and turnover together.

Alpha lipoic acid and its reduced form regenerate glutathione, vitamin C and vitamin E after they quench a radical. It sits in the same hepatic antioxidant network silymarin supports and the pairing is long-standing formulation practice.

Selenium is built into glutathione peroxidase, the selenoenzyme that spends glutathione to reduce lipid hydroperoxides. It makes the glutathione pool silymarin helps maintain usable.

Schisandra lignans and silymarin flavonolignans both act on hepatic phase I and phase II enzyme expression, including glutathione S-transferase. They have been formulated together in liver blends for decades.

Artichoke cynarin acts on bile secretion and flow, which is how fat-soluble waste leaves the liver. Silymarin works on the hepatocyte membrane and redox side, so the pair covers cell and outflow.

Dandelion root is a bitter that stimulates bile production and normal digestive secretion. It is combined with silymarin in liver formulas for the same cell-plus-outflow logic as artichoke.

Curcumin and silymarin both act on the Nrf2 pathway that switches on phase II conjugating enzymes such as glutathione S-transferase and NAD(P)H quinone oxidoreductase. Their effects on that transcriptional programme overlap.

Silybin is cleared mainly by UGT glucuronidation, and piperine slows that conjugation step. Co-dosing raises silybin exposure, and the same inhibition applies to other actives in the formula.

Betaine donates methyl groups to remethylate homocysteine to methionine, feeding the SAM-e pool that makes phosphatidylcholine. That phospholipid is needed to package and export fat out of liver cells, a different lever than the antioxidant one silymarin pulls.

Choline is the head group of phosphatidylcholine, which liver cells require to assemble and release VLDL particles. Pairing it with silymarin covers lipid handling alongside redox support.

Flavonolignans carry the catechol and hydroxyl groups that bind ferrous and ferric iron in the gut lumen, lowering uptake of a non-heme iron salt taken at the same time. Space the two by a couple of hours rather than combining them in one dose.

Silymarin flavonolignans are poorly water soluble, so the amount that dissolves in the gut fluid sets the ceiling on how much can be absorbed. A krill oil based formulation was studied as a lipid carrier for the extract, with phospholipid-rich oil acting as the dispersing vehicle. The reported readout is dissolution and appearance in circulation, which is an absorption marker rather than a clinical outcome.

Silybin and its sister flavonolignans dissolve poorly in water and better in lipid systems. Medium chain triglycerides are used in soft capsules to keep the extract dispersed rather than settled as dry powder. The rationale is formulation chemistry, not a combination trial, so read it as mechanistic.

Long chain omega-3 oils serve the same dispersing role as other lipids for a fat-soluble botanical extract. Products that pair the two generally do so to hold silymarin in solution inside a softgel. No combination trial supports a joint effect beyond that dispersion role.

Both extracts are polyphenol-rich and were examined together against markers of antioxidant status in farm animals. The measured endpoints were blood biomarkers, not health outcomes, and the work was done in animals rather than people. It grounds a shared antioxidant mechanism and nothing stronger.

Ascorbate sits in the water phase and regenerates oxidised phenolic radicals, including flavonoid species of the kind found in silymarin. The pairing spreads antioxidant coverage across both the aqueous and membrane compartments. This is redox chemistry rather than an outcome claim.

Alpha-tocopherol terminates lipid radical chains inside membranes, while silymarin flavonolignans partition at the membrane surface. The two act on the same lipid peroxidation sequence at different points. Formulators pair them for that reason; the basis is chemistry, not a joint trial.

Glycine is one of the three amino acids condensed into glutathione, alongside cysteine and glutamate. Supplying it supports the substrate side of a pathway that silymarin is studied against on the antioxidant side. The relationship is a precursor supply step, not a combination result.

Cysteine availability normally sets the pace of glutathione synthesis in liver cells. Pairing a cysteine source with a botanical studied for antioxidant support addresses supply and demand on the same pathway. Free cysteine oxidises readily, which is why most formulas use a stabilised source instead.

Methionine feeds the transsulfuration route that generates cysteine and, downstream, glutathione. That places it upstream of the same antioxidant pool silymarin is studied against. High intakes also raise homocysteine unless the methylation cofactors are present, which is the trade-off to note.

SAM-e is the methyl donor generated from methionine and the branch point that feeds cysteine and glutathione production in the liver. It and milk thistle extract are commonly formulated into the same liver-support products. No head-to-head combination trial defines the joint effect, so the grounding is pathway overlap.

Methylfolate donates the methyl group that regenerates methionine from homocysteine, keeping the upstream supply for hepatic methylation and glutathione synthesis intact. It sits on the same metabolic map as milk thistle extract without acting on the same target. The link is pathway adjacency and should be read that way.

Taurine conjugates bile acids and so participates in normal bile flow, which is also the route by which silymarin conjugates are excreted. The two are formulated together in bile-support products on that basis. This describes handling and excretion, not a demonstrated joint effect.

The catechol and phenolic hydroxyl groups on silybin bind ferric iron, the same chemistry that lets polyphenols lower non-heme iron absorption. Taken in the same sitting as an iron supplement, the extract can reduce how much iron is taken up. Separating the two by a couple of hours is the usual formulation answer.

Zinc is a structural cofactor for copper-zinc superoxide dismutase, one of the enzymes that clears superoxide inside cells. Silymarin is studied on the non-enzymatic side of the same redox picture. Very high zinc intakes also compete with copper uptake, which is the trade-off in a long-running formula.

Ubiquinol works inside the mitochondrial membrane and regenerates tocopherol radicals, extending the same lipid antioxidant network silymarin partitions into. Both are lipophilic and share a lipid vehicle well in a softgel. The pairing rests on redox chemistry rather than a combination trial.

Quercetin and the silymarin flavonolignans are both handled by intestinal and hepatic glucuronidation and sulfation. Given together they can compete for those conjugating enzymes, which changes exposure to each in ways that have not been quantified in people. The overlap is worth flagging in either direction rather than assumed to be additive.

Resveratrol undergoes heavy first-pass sulfation and glucuronidation, the same phase II routes that limit silymarin exposure. Co-dosing can shift how much of either reaches circulation. Stack them knowingly; the direction of the shift is not established in humans.

Grape seed proanthocyanidins scavenge radicals and chelate transition metals through the same phenolic groups silybin carries. Products pair them for broader polyphenol coverage. Both also bind dietary iron, so the chelation caveat applies to the pair as much as to either alone.

Pine bark procyanidins act on the same lipid peroxidation and metal chelation chemistry as silymarin flavonolignans. The combination is common in antioxidant formulas rather than in trials. Read the pairing as chemistry-led.

Astaxanthin spans the lipid bilayer and quenches singlet oxygen at both membrane surfaces, a position no phenolic covers. Silymarin sits at the polar interface instead. Together they cover different depths of the same membrane, and both need a lipid vehicle to disperse.

EGCG and silymarin flavonolignans compete for the same glucuronidation and sulfation capacity in gut wall and liver. High-dose concentrated green tea extract carries its own hepatic caution in case reports, which is a reason to keep total polyphenol load in view when stacking. The interaction is metabolic, not synergistic in any measured sense.

Silymarin components inhibit several cytochrome P450 isoforms and P-glycoprotein in laboratory systems, and berberine is a substrate for that same machinery. Co-dosing can raise or lower berberine exposure depending on which route dominates. The evidence sits in in vitro work, so it is a flag to formulators rather than a quantified effect.

Glutamine is deamidated to glutamate, the third amino acid in the glutathione tripeptide. Supplying it supports the substrate pool that hepatic antioxidant defence draws on. This is a precursor relationship, not a co-studied combination.

Silymarin conjugates are secreted in bile and reach the colon, where bacterial enzymes can deconjugate them and allow reabsorption. Shifting the resident microbiota therefore has a plausible effect on how long the compounds circulate. The mechanism is described in preclinical work; no human combination data defines the size of it.